Setareh Seyedkazemi, Chief Development Officer at Adverum Biotechnologies, Inc. (ADVM), sold 6,058 shares at $1.07 ($6K) on 2022-09-19, disclosed to the SEC on 2022-09-21.
Open-market sale of $6k ADVM by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADVM | BUY | 2022-05-24 | $17K | — | Filing → |